- Data limitations due to company stage and refinements in measurement methods.
Rocket Pharmaceuticals, Inc.
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Rocket Pharmaceuticals, Inc. disclosed greenhouse gas emissions of 2.4K MT CO2e. By scope: Scope 1: 529 MT CO2e; Scope 2: 1.9K MT CO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
2.4K MT CO2e
2023
Waste
3.4M lbs (biological waste)
2023
Energy Use
6.4M kWh
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 529 MT CO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 1.9K MT CO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Reduced greenhouse gas emissions (Scope 1 and 2 combined) from 2358 MT CO2e in 2022 to 2418 MT CO2e in 2023. All biological waste diverted from landfill and recycled.
- Installed electronic car charging stations at Cranbury, NJ facility.
- Implemented energy-efficient appliances, power monitoring, and LED lighting.
🌱 ESG Focus Areas
Employee Engagement, Recruitment and RetentionDiversity, Equity, and InclusionOccupational Health and Safety ManagementClinical Trial Program and SafetyAccess to MedicinesProduct SafetySupply Chain ManagementCommunity EngagementEnergy ManagementWaste ManagementBusiness EthicsData Security and Privacy